These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10548241)

  • 21. [Abnormal coagulation in critical care patients].
    Pettilä V
    Duodecim; 2004; 120(14):1745-52. PubMed ID: 15497308
    [No Abstract]   [Full Text] [Related]  

  • 22. The incidence of thromboembolism in the surgical intensive care unit.
    Major KM; Wilson M; Nishi GK; Farber A; Chopra R; Chung A; McVay C; Spivak J; Shabot MM
    Am Surg; 2003 Oct; 69(10):857-61. PubMed ID: 14570363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin.
    Nurmohamed SA; Jallah BP; Vervloet MG; Beishuizen A; Groeneveld AB
    ASAIO J; 2011; 57(1):48-52. PubMed ID: 21084966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular-weight heparin in preventing and treating DVT.
    Rydberg EJ; Westfall JM; Nicholas RA
    Am Fam Physician; 1999 Mar; 59(6):1607-12. PubMed ID: 10193600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study.
    Cook D; Laporta D; Skrobik Y; Peters S; Sharpe M; Murphy P; Chin D; Crowther M;
    J Crit Care; 2001 Dec; 16(4):161-6. PubMed ID: 11815901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboprophylaxis in arthroscopic surgery.
    Anand A
    Arthroscopy; 2014 Jul; 30(7):780. PubMed ID: 24951355
    [No Abstract]   [Full Text] [Related]  

  • 27. Authors' reply.
    Sun Y; Jiang Q
    Arthroscopy; 2014 Jul; 30(7):780. PubMed ID: 24951354
    [No Abstract]   [Full Text] [Related]  

  • 28. Summaries for patients. Low-molecular-weight heparin given for several weeks after hip surgery prevents deep venous thrombosis.
    Ann Intern Med; 2001 Nov; 135(10):S-55. PubMed ID: 11757493
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.
    Klerk CP; Smorenburg SM; Büller HR
    Arch Intern Med; 2003 Sep; 163(16):1913-21. PubMed ID: 12963564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the utility of venous thrombosis prophylaxis in orthopedic surgery patients.
    Carrier M; Cushman M
    Ann Intern Med; 2012 May; 156(10):748-9. PubMed ID: 22412037
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombotic complications at altitude.
    Zafren K
    Wilderness Environ Med; 2004; 15(2):155. PubMed ID: 15228070
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-molecular-weight heparin for anticoagulation during continuous venovenous hemofiltration.
    Knight DJ; Selwyn D; Girling K
    Arch Intern Med; 2003 Apr; 163(8):981; author reply 981. PubMed ID: 12719210
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1024-5. PubMed ID: 11484301
    [No Abstract]   [Full Text] [Related]  

  • 34. Forward thinking in orthopaedic surgery prophylaxis.
    Pownall M
    Hosp Med; 2005 Apr; 66(4):242-3. PubMed ID: 15889876
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter 1: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Wille-Jorgensen P
    Br J Surg; 2006 Mar; 93(3):374; author reply 375-6. PubMed ID: 16498577
    [No Abstract]   [Full Text] [Related]  

  • 36. Perioperative use of low-molecular-weight heparin.
    Cannavo D
    J Bone Joint Surg Am; 2000 Nov; 82(11):1673-4. PubMed ID: 11097465
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin and CXCL12 dimerization.
    Altundag K; Altundag O; Atik MA
    J Clin Oncol; 2005 Oct; 23(28):7248. PubMed ID: 16192624
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of venous thromboembolism after acute ischaemic stroke.
    Ricci S; Celani MG; Righetti E; Dennis M; Sandercock P
    Lancet; 2007 Sep; 370(9589):735-6; author reply 736-7. PubMed ID: 17765511
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.
    Cope J; Bushwitz J; An G; Antigua A; Patel A; Zumberg M
    Ann Pharmacother; 2015 Mar; 49(3):270-7. PubMed ID: 25515864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter 3: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Agnelli G; Bergqvist D; Dahl O; Eriksson B; Rud Lassen M; Mouret P; Rosencher N
    Br J Surg; 2006 Mar; 93(3):375; author reply 375-6. PubMed ID: 16498579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.